Viyash Scientific Q4 EBITDA Crosses ₹200 Cr

Viyash Scientific posted Q4 FY26 revenue of ₹9,200 million, up 19.1% YoY, and EBITDA of ₹2,001 million, up 63.9%.
Full‑year FY26 revenue reached ₹34,203 million (+13.8% YoY), EBITDA ₹7,025 million (+59.6%), and PAT surged to ₹2,246 million (+1,324%).
Net debt‑to‑EBITDA ratio fell to 0.2x, indicating a highly deleveraged balance sheet per MD & Group CEO Dr Hari Babu Bodepudi.
The company highlighted integration synergies, disciplined asset utilisation, cost controls and selective inorganic opportunities amid geopolitical and maritime disruptions.